Our story: Small firm striving for big impact.

In the early months of 2026, Waters Molecular & Surgery was founded in a San Antonio workshop with a single objective: innovate for those who need it most. With a focus on biomedical innovation, the firm strives to fulfill this goal by conducting thorough research, then developing quality products for the laboratory and the clinical setting.

It all began when the firm's founder, Jack Waters, became interested in better understanding the pathophysiology of decompensated shock. Through countless hours, intensive effort, careful study, and some trial coupled with error, the firm produced its first research system — the Venetian Circulation — now being used to study the fluid dynamics of decompensated shock.

Soon after, the firm presented its work and was awarded a $1,000 startup grant. With early funding and momentum from the initial success of the Venetian Circulation, the firm aggressively expanded its research interests. With multiple ongoing projects, outreach, and products soon to be launched, Waters Molecular & Surgery is poised to make an impact for patients, clinicians, researchers, and students.